180 related articles for article (PubMed ID: 20684009)
1. Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair study.
Biancone L; Petruzziello C; Orlando A; Kohn A; Ardizzone S; Daperno M; Angelucci E; Castiglione F; D'Incà R; Zorzi F; Papi C; Meucci G; Riegler G; Sica G; Rizzello F; Mocciaro F; Onali S; Calabrese E; Cottone M; Pallone F
Inflamm Bowel Dis; 2011 Mar; 17(3):758-66. PubMed ID: 20684009
[TBL] [Abstract][Full Text] [Related]
2. Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study.
Biancone L; Orlando A; Kohn A; Colombo E; Sostegni R; Angelucci E; Rizzello F; Castiglione F; Benazzato L; Papi C; Meucci G; Riegler G; Petruzziello C; Mocciaro F; Geremia A; Calabrese E; Cottone M; Pallone F
Gut; 2006 Feb; 55(2):228-33. PubMed ID: 16120759
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: a population-based study.
Crombé V; Salleron J; Savoye G; Dupas JL; Vernier-Massouille G; Lerebours E; Cortot A; Merle V; Vasseur F; Turck D; Gower-Rousseau C; Lémann M; Colombel JF; Duhamel A
Inflamm Bowel Dis; 2011 Oct; 17(10):2144-52. PubMed ID: 21287665
[TBL] [Abstract][Full Text] [Related]
4. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.
Schnitzler F; Fidder H; Ferrante M; Noman M; Arijs I; Van Assche G; Hoffman I; Van Steen K; Vermeire S; Rutgeerts P
Inflamm Bowel Dis; 2009 Sep; 15(9):1295-301. PubMed ID: 19340881
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: a multicenter international cohort.
Juillerat P; Sokol H; Froehlich F; Yajnik V; Beaugerie L; Lucci M; Burnand B; Macpherson AJ; Cosnes J; Korzenik JR
Inflamm Bowel Dis; 2015 Jan; 21(1):60-70. PubMed ID: 25517594
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
[TBL] [Abstract][Full Text] [Related]
7. Adalimumab and infliximab are equally effective for Crohn's disease in patients not previously treated with anti-tumor necrosis factor-α agents.
Kestens C; van Oijen MG; Mulder CL; van Bodegraven AA; Dijkstra G; de Jong D; Ponsioen C; van Tuyl BA; Siersema PD; Fidder HH; Oldenburg B;
Clin Gastroenterol Hepatol; 2013 Jul; 11(7):826-31. PubMed ID: 23376000
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort.
Schnitzler F; Fidder H; Ferrante M; Noman M; Arijs I; Van Assche G; Hoffman I; Van Steen K; Vermeire S; Rutgeerts P
Gut; 2009 Apr; 58(4):492-500. PubMed ID: 18832518
[TBL] [Abstract][Full Text] [Related]
9. Elective switching from infliximab to adalimumab in stable Crohn's disease.
Hoentjen F; Haarhuis BJ; Drenth JP; de Jong DJ
Inflamm Bowel Dis; 2013; 19(4):761-6. PubMed ID: 23446337
[TBL] [Abstract][Full Text] [Related]
10. An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
Sugimoto K; Ikeya K; Iida T; Kawasaki S; Arai O; Umehara K; Watanabe F; Tani S; Oishi S; Osawa S; Yamamoto T; Hanai H
Dig Dis Sci; 2016 Jan; 61(1):99-106. PubMed ID: 26254083
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective study.
Paul S; Del Tedesco E; Marotte H; Rinaudo-Gaujous M; Moreau A; Phelip JM; Genin C; Peyrin-Biroulet L; Roblin X
Inflamm Bowel Dis; 2013 Nov; 19(12):2568-76. PubMed ID: 24013361
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn's Disease.
Benmassaoud A; Al-Taweel T; Sasson MS; Moza D; Strohl M; Kopylov U; Paradis-Surprenant L; Almaimani M; Bitton A; Afif W; Lakatos PL; Bessissow T
Dig Dis Sci; 2018 May; 63(5):1302-1310. PubMed ID: 29243105
[TBL] [Abstract][Full Text] [Related]
13. Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease.
Gagniere C; Beaugerie L; Pariente B; Seksik P; Amiot A; Abitbol V; Allez M; Cosnes J; Sokol H
J Crohns Colitis; 2015 Apr; 9(4):349-55. PubMed ID: 25547977
[TBL] [Abstract][Full Text] [Related]
14. The extra burden of infliximab infusions in inflammatory bowel disease.
Buisson A; Seigne AL; Dʼhuart MC; Bigard MA; Peyrin-Biroulet L
Inflamm Bowel Dis; 2013 Oct; 19(11):2464-7. PubMed ID: 23942563
[TBL] [Abstract][Full Text] [Related]
15. Infliximab and pediatric stricturing Crohn's disease: a possible alternative to surgery? Experience of seven cases.
Gasparetto M; Corradin S; Vallortigara F; Cananzi M; Guariso G
Acta Gastroenterol Belg; 2012 Mar; 75(1):58-60. PubMed ID: 22567750
[TBL] [Abstract][Full Text] [Related]
16. Treatment with infliximab for pediatric Crohn's disease: Nationwide survey of Japan.
Hosoi K; Ohtsuka Y; Fujii T; Kudo T; Matsunaga N; Tomomasa T; Tajiri H; Kunisaki R; Ishige T; Yamada H; Arai K; Yoden A; Ushijima K; Aomatsu T; Nagata S; Uchida K; Takeuchi K; Shimizu T
J Gastroenterol Hepatol; 2017 Jan; 32(1):114-119. PubMed ID: 27478130
[TBL] [Abstract][Full Text] [Related]
17. Accelerated Step-Up Infliximab Use Is Associated with Sustained Primary Response in Pediatric Crohn's Disease.
Ling J; Buurman D; Ravikumara M; Mews C; Thacker K; Grover Z
Dig Dis Sci; 2018 Apr; 63(4):1003-1010. PubMed ID: 29480415
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic monitoring of infliximab therapy in Crohn's disease.
af Björkesten CG; Nieminen U; Turunen U; Arkkila PE; Sipponen T; Färkkilä MA
Inflamm Bowel Dis; 2011 Apr; 17(4):947-53. PubMed ID: 20860048
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational study.
Miheller P; Lakatos PL; Horváth G; Molnár T; Szamosi T; Czeglédi Z; Salamon A; Czimmer J; Rumi G; Palatka K; Papp M; Jakab Z; Szabó A; Gelley A; Lakatos L; Barta Z; Balázs C; Rácz I; Zeher M; Döbrönte Z; Altorjay I; Hunyady B; Simon L; Papp J; Banai J; Nagy F; Lonovics J; Ujszászy L; Muzes G; Herszényi L; Tulassay Z
BMC Gastroenterol; 2009 Sep; 9():66. PubMed ID: 19740450
[TBL] [Abstract][Full Text] [Related]
20. Mucosal healing in pediatric Crohn's disease after anti-TNF therapy: a long-term experience at a single center.
Nobile S; Gionchetti P; Rizzello F; Calabrese C; Campieri M
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):458-65. PubMed ID: 24445727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
